Children treated for Langerhans cell histiocytosis (LCH) are at risk for short and long term endocrine sequelae, but biological predictors of specific deficits are not well defined. We evaluated the frequency and progression of LCH-related endocrine deficits during long term follow-up and assessed the ability of dynamic endocrine testing to identify patients at risk for late anterior or posterior pituitary hormone dysfunction. The 17 patients (5 males and 12 females) were followed a median of 10 yr after diagnosis of single system (n = 6) or multisystem (n = 11) disease. Study evaluations, performed a median of 4.1 yr after the diagnosis, comprised pituitary hormone responses to the appropriate challenge, 7-h water deprivation test, 3\% hyp...
Neurodegenerative Langerhans Cell Histiocytosis (ND-LCH) is a rare, unpredictable consequence that m...
Objective: To analyze the effectiveness and safety of growth hormone (GH) replacement treatment in a...
Objective: To analyze the effectiveness and safety of growth hormone (GH) replacement treatment in a...
Children treated for Langerhans cell histiocytosis (LCH) are at risk for short and long term endocri...
Aim To compare the MR changes in the hypothalmo-pituitary region in LCH patients with or without pit...
Langerhans cell histiocytosis (LCH) is a rare disorder in which granulomatous deposits occur at mult...
Langerhans cell histiocytosis (LCH) is a disorder of the mononuclear phagocyte system that can affec...
International audienceOBJECTIVE: Langerhans Cell Histiocytosis (LCH) is a rare inflammatory myeloid ...
To describe the MR findings in the hypothalamic pituitary area in children with Langerhans cell hist...
Background: Langerhans cell histiocytosis (LCH) is a rare histiocytic disorder of unknown etiopathog...
To assess pituitary vascularization in children with hypopituitarism, central diabetes insipidus (DI...
Conclusion: GH deficiency is not a common manifestation of LCH in childhood and GH provocation tests...
Langerhans cell histiocytosis is a rare, multisystem disease that shows a particular predilection fo...
<div><p>Background</p><p>Neurodegenerative Langerhans Cell Histiocytosis (ND-LCH) is a rare, unpredi...
Neurodegenerative Langerhans Cell Histiocytosis (ND-LCH) is a rare, unpredictable consequence that m...
Objective: To analyze the effectiveness and safety of growth hormone (GH) replacement treatment in a...
Objective: To analyze the effectiveness and safety of growth hormone (GH) replacement treatment in a...
Children treated for Langerhans cell histiocytosis (LCH) are at risk for short and long term endocri...
Aim To compare the MR changes in the hypothalmo-pituitary region in LCH patients with or without pit...
Langerhans cell histiocytosis (LCH) is a rare disorder in which granulomatous deposits occur at mult...
Langerhans cell histiocytosis (LCH) is a disorder of the mononuclear phagocyte system that can affec...
International audienceOBJECTIVE: Langerhans Cell Histiocytosis (LCH) is a rare inflammatory myeloid ...
To describe the MR findings in the hypothalamic pituitary area in children with Langerhans cell hist...
Background: Langerhans cell histiocytosis (LCH) is a rare histiocytic disorder of unknown etiopathog...
To assess pituitary vascularization in children with hypopituitarism, central diabetes insipidus (DI...
Conclusion: GH deficiency is not a common manifestation of LCH in childhood and GH provocation tests...
Langerhans cell histiocytosis is a rare, multisystem disease that shows a particular predilection fo...
<div><p>Background</p><p>Neurodegenerative Langerhans Cell Histiocytosis (ND-LCH) is a rare, unpredi...
Neurodegenerative Langerhans Cell Histiocytosis (ND-LCH) is a rare, unpredictable consequence that m...
Objective: To analyze the effectiveness and safety of growth hormone (GH) replacement treatment in a...
Objective: To analyze the effectiveness and safety of growth hormone (GH) replacement treatment in a...